---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-26-001153"
form_type: "8-K"
ticker: "CDIO"
cik: "0001870144"
company_name: "Cardio Diagnostics Holdings, Inc."
filed_at: "2026-08-20T12:03:24+00:00"
generated_at: "2026-08-20T12:05:44.409191+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CDIO investor deck: CMS $854/test rate set; Atlas coverage; Dr. Lal PathLabs India deal; lab scale-up

## Summary
- CMS final payment rate of $854 per test set (Dec 2025) for both Epi+Gen CHD (0439U) and PrecisionCHD (0440U) CPT codes.
- Atlas Healthcare Physicians began in-network coverage with prior authorization (June 2026); out-of-network billing launched July 2026.
- Dr. Lal PathLabs (290+ labs, 300+ pathologists) to offer PrecisionCHD in India; Aimil Ltd partnership extends distribution network.
- Company-owned CLIA lab now processing tests in-house, cutting initial COGS ~30%; turnaround time 7-10 business days.
- Combined US TAM ~$175B: 146M eligible for Epi+Gen CHD risk test, 60M for PrecisionCHD diagnostic; 40% gross margin target at scale.

## SEC filing metadata
- accession: 0001079973-26-001153
- form_type: 8-K
- ticker: CDIO
- cik: 0001870144
- company_name: Cardio Diagnostics Holdings, Inc.
- filed_at: 2026-08-20T12:03:24+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870144/000107997326001153/0001079973-26-001153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870144/000107997326001153/cdio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-26-001153
- JSON: https://secwatch.observer/filing/0001079973-26-001153.json
- Plain text: https://secwatch.observer/filing/0001079973-26-001153.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.